Lamote K[au] - Search Results

Year	Number of Results
2013	1
2014	1
2016	1
2017	3
2018	1
2019	2
2020	4
2021	2

1

Volatomics in inflammatory bowel disease and irritable bowel syndrome.

Van Malderen K, De Winter BY, De Man JG, De Schepper HU, Lamote K. Van Malderen K, et al. Among authors: lamote k. EBioMedicine. 2020 Apr;54:102725. doi: 10.1016/j.ebiom.2020.102725. Epub 2020 Apr 21. EBioMedicine. 2020. PMID: 32330874 Free PMC article. Review.

2

The electronic nose: emerging biomarkers in lung cancer diagnostics.

van Geffen WH, Lamote K, Costantini A, Hendriks LEL, Rahman NM, Blum TG, van Meerbeeck J. van Geffen WH, et al. Among authors: lamote k. Breathe (Sheff). 2019 Dec;15(4):e135-e141. doi: 10.1183/20734735.0309-2019. Breathe (Sheff). 2019. PMID: 32280381 Free PMC article. Review.

3

A Literature Review of the Potential Diagnostic Biomarkers of Head and Neck Neoplasms.

Konings H, Stappers S, Geens M, De Winter BY, Lamote K, van Meerbeeck JP, Specenier P, Vanderveken OM, Ledeganck KJ. Konings H, et al. Among authors: lamote k. Front Oncol. 2020 Jun 26;10:1020. doi: 10.3389/fonc.2020.01020. eCollection 2020. Front Oncol. 2020. PMID: 32670885 Free PMC article. Review.

4

Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review.

Janssens E, van Meerbeeck JP, Lamote K. Janssens E, et al. Among authors: lamote k. Crit Rev Oncol Hematol. 2020 Sep;153:103037. doi: 10.1016/j.critrevonc.2020.103037. Epub 2020 Jul 1. Crit Rev Oncol Hematol. 2020. PMID: 32771940 Review.

5

The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers?

Lamote K, Janssens E, Schillebeeckx E, Lapperre TS, De Winter BY, van Meerbeeck JP. Lamote K, et al. J Breath Res. 2020 Jul 21;14(4):042001. doi: 10.1088/1752-7163/aba105. J Breath Res. 2020. PMID: 32599571 No abstract available.

6

Management of incidental nodules in lung cancer screening: ready for prime-time?

Kanellakis NI, Lamote K. Kanellakis NI, et al. Among authors: lamote k. Breathe (Sheff). 2019 Dec;15(4):346-349. doi: 10.1183/20734735.0247-2019. Breathe (Sheff). 2019. PMID: 31803272 Free PMC article.

7

Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?

Lagniau S, Lamote K, van Meerbeeck JP, Vermaelen KY. Lagniau S, et al. Among authors: lamote k. Oncotarget. 2017 May 17;8(32):53751-53762. doi: 10.18632/oncotarget.17910. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881848 Free PMC article. Review.

8

Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.

Brusselmans L, Arnouts L, Millevert C, Vandersnickt J, van Meerbeeck JP, Lamote K. Brusselmans L, et al. Among authors: lamote k. Transl Lung Cancer Res. 2018 Oct;7(5):520-536. doi: 10.21037/tlcr.2018.04.09. Transl Lung Cancer Res. 2018. PMID: 30450290 Free PMC article. Review.

9

Fibulin-3 as a biomarker for pleural mesothelioma.

Lamote K, Baas P, van Meerbeeck JP. Lamote K, et al. N Engl J Med. 2013 Jan 10;368(2):189-90. doi: 10.1056/NEJMc1213514. N Engl J Med. 2013. PMID: 23301745 No abstract available.

10

Exhaled breath to screen for malignant pleural mesothelioma: a validation study.

Lamote K, Vynck M, Thas O, Van Cleemput J, Nackaerts K, van Meerbeeck JP. Lamote K, et al. Eur Respir J. 2017 Dec 21;50(6):1700919. doi: 10.1183/13993003.00919-2017. Print 2017 Dec. Eur Respir J. 2017. PMID: 29269578 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results